- Pleural mesothelioma is the most common form of the cancer, affecting the lining of the lungs, called the pleura.
- Peritoneal mesothelioma is the second most common form of the cancer and develops in the lining of the abdomen, called the peritoneum.
- Pericardial mesothelioma develops in the membrane that surrounds the heart, called the pericardium.
- Testicular mesothelioma is the rarest form of the cancer and develops in the membranous lining surrounding the testicles, called the tunica vaginalis.
Monday, 26 April 2010
Malignant Mesothelioma Types
Medical professionals divide malignant mesothelioma into various types depending on which area of the mesothelium is affected:
Malignant Mesothelioma Symptoms
Patients with malignant mesothelioma generally do not display any symptoms until 20 to 50 years after exposure to asbestos occurs. This is due to the long latency period (the amount of time it takes for a patient to demonstrate symptoms after initial exposure to a disease-causing agent) associated with mesothelioma. The symptoms of mesothelioma are very general and often resemble less serious conditions, which can make diagnosis difficult.
Symptoms vary depending on the type of mesothelioma a patient has, but the most common symptoms expressed by pleural mesothelioma patients include shortness of breath, chest pain and persistent cough. Peritoneal mesothelioma patients may display symptoms such as abdominal swelling, changes in bowel movement and development of lumps under the skin on the abdomen. Patients with pericardial mesothelioma may experience heart palpitations, chest pain, difficulty breathing and fever or night sweats. Testicular mesothelioma patients may notice testicular lumps.
Asbestos.com offers a complimentary informational packet personalized to a patient’s specific mesothelioma diagnosis. With information about the cancer, treatment options and top doctors, many patients and their loved ones find the packet to be a valuable resource. Click here for more information or to receive your complimentary packet overnight.
Symptoms vary depending on the type of mesothelioma a patient has, but the most common symptoms expressed by pleural mesothelioma patients include shortness of breath, chest pain and persistent cough. Peritoneal mesothelioma patients may display symptoms such as abdominal swelling, changes in bowel movement and development of lumps under the skin on the abdomen. Patients with pericardial mesothelioma may experience heart palpitations, chest pain, difficulty breathing and fever or night sweats. Testicular mesothelioma patients may notice testicular lumps.
Asbestos.com offers a complimentary informational packet personalized to a patient’s specific mesothelioma diagnosis. With information about the cancer, treatment options and top doctors, many patients and their loved ones find the packet to be a valuable resource. Click here for more information or to receive your complimentary packet overnight.
Malignant Mesothelioma
Malignant mesothelioma is a form of asbestos cancer that affects the thin tissue layer surrounding the body's internal organs, called the mesothelium. The cancer is almost exclusively caused by asbestos exposure.
In an effort to help patients understand mesothelioma, Asbestos.com offers a complimentary packet that contains treatment information tailored to your specific diagnosis. The packet also covers the nation's top mesothelioma doctors and cancer centers, as well as financial assistance options to help cover medical costs. To receive your packet in the mail, please enter your information below.
In an effort to help patients understand mesothelioma, Asbestos.com offers a complimentary packet that contains treatment information tailored to your specific diagnosis. The packet also covers the nation's top mesothelioma doctors and cancer centers, as well as financial assistance options to help cover medical costs. To receive your packet in the mail, please enter your information below.
Varying Latency Periods
A number of studies have been conducted on the specifics of the length of latency periods among those exposed to asbestos.
In the case of mesothelioma, evidence has indicated that high exposure for short periods of time might be more damaging than low exposure for many years. For example, Deborah Reeve, a New York City paramedic and first responder at the site of the World Trade Center attacks in 2001, passed away from mesothelioma in 2006, just five years after her exposure to asbestos from the events on September 11. Deborah had symptoms of the disease as early as 2003 and was diagnosed with mesothelioma in 2004.
Numerous studies on asbestosis agree that more than 90 percent of individuals who were exposed to asbestos for 40 years or more will develop the disease. For those who worked with the toxic mineral for 20-30 years, the rate is about 75 percent. Those who experienced 10-19 years of exposure have an incidence level of about 10 to 15 percent. These numbers may also vary according to the level of asbestos someone is exposed to on a daily basis.
For example, shipbuilders of the mid-20th century were nearly always surrounded by asbestos as were many construction workers. Those groups have tended to develop asbestosis sooner than those who worked in other industries where the levels may not have been as high.
Patients concerned about the latency period associated with mesothelioma and the possibility of developing the cancer may be interested to read more about mesothelioma symptoms.
Sources:
In the case of mesothelioma, evidence has indicated that high exposure for short periods of time might be more damaging than low exposure for many years. For example, Deborah Reeve, a New York City paramedic and first responder at the site of the World Trade Center attacks in 2001, passed away from mesothelioma in 2006, just five years after her exposure to asbestos from the events on September 11. Deborah had symptoms of the disease as early as 2003 and was diagnosed with mesothelioma in 2004.
Numerous studies on asbestosis agree that more than 90 percent of individuals who were exposed to asbestos for 40 years or more will develop the disease. For those who worked with the toxic mineral for 20-30 years, the rate is about 75 percent. Those who experienced 10-19 years of exposure have an incidence level of about 10 to 15 percent. These numbers may also vary according to the level of asbestos someone is exposed to on a daily basis.
For example, shipbuilders of the mid-20th century were nearly always surrounded by asbestos as were many construction workers. Those groups have tended to develop asbestosis sooner than those who worked in other industries where the levels may not have been as high.
Patients concerned about the latency period associated with mesothelioma and the possibility of developing the cancer may be interested to read more about mesothelioma symptoms.
Sources:
mesothelioma Latency Period
The term latency period is used to describe the period of time between exposure to a potential disease-causing agent and the time the disease becomes apparent. According to most experts, in the case of mesothelioma the latency period ranges from 20 to 50 years after initial exposure to asbestos occurred, though there have been instances when the time period was shorter or longer.
Due to the long latency period associated with the cancer, those exposed to asbestos during the 1950s, '60s and '70s are beginning to demonstrate mesothelioma symptoms today, decades after they were exposed to asbestos.
Due to the long latency period associated with the cancer, those exposed to asbestos during the 1950s, '60s and '70s are beginning to demonstrate mesothelioma symptoms today, decades after they were exposed to asbestos.
Living During the Latency Period
While no one should spend their days dwelling on the fact that they could someday develop an asbestos-related disease, there are some things that can be done to aid in early diagnosis if mesothelioma is indeed present.
The most notable development in the last few years is the mesothelioma blood test known as Mesomark. Approved by the FDA in 2007, this simple test measures a particular cancer biomarker and can catch mesothelioma in the early stages of development. The blood test is not available everywhere but if you wish to undergo testing, asking your doctor where you may take advantage of the test may aid in early detection.
Those exposed to asbestos run the risk of developing asbestosis or mesothelioma and may wish to schedule yearly chest X-rays to check for any suspicious signs of disease. If a doctor determines there may be a concern after the X-ray, further imaging tests such as CT scans or MRIs may be recommended. A biopsy may also be requested to test for the presence of cancerous cells.
Asbestos.com offers additional information about mesothelioma diagnosis, treatment and top doctors though a complimentary comprehensive packet. Please click here to receive your copy.
The most notable development in the last few years is the mesothelioma blood test known as Mesomark. Approved by the FDA in 2007, this simple test measures a particular cancer biomarker and can catch mesothelioma in the early stages of development. The blood test is not available everywhere but if you wish to undergo testing, asking your doctor where you may take advantage of the test may aid in early detection.
Those exposed to asbestos run the risk of developing asbestosis or mesothelioma and may wish to schedule yearly chest X-rays to check for any suspicious signs of disease. If a doctor determines there may be a concern after the X-ray, further imaging tests such as CT scans or MRIs may be recommended. A biopsy may also be requested to test for the presence of cancerous cells.
Asbestos.com offers additional information about mesothelioma diagnosis, treatment and top doctors though a complimentary comprehensive packet. Please click here to receive your copy.
ncreased susceptibility to infection. Chemotherapy Medications for Mesothelioma Patients
Today's most commonly used chemotherapy medication for mesothelioma is Alimta. Currently, this drug is the only FDA-approved medication specifically designed for the treatment of malignant mesothelioma when surgery is not an option. It is generally used in combination with another chemotherapy drug called cisplatin, a platinum-based drug. Together, the two have shown promise in prolonging and improving the quality of life of mesothelioma patients. Other chemotherapy drugs sometimes used for mesothelioma treatment include carboplatin, onconase, gemcitabine, and navelbine.
Subscribe to:
Posts (Atom)